John‐Michael Sauer

3.1k citations

44 papers · 1.9k indexed · h-index 20

Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 8
- Treatment of Major Depression 7
Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 8
- Treatment of Major Depression 7
Psychiatry and Mental health top 5%
- Attention Deficit Hyperactivity Disorder 4
Cellular and Molecular Neuroscience top 5%
Toxicology top 5%
Economics and Econometrics
- Health Systems, Economic Evaluations, Quality of Life 6
Statistics and Probability
- Statistical Methods in Clinical Trials 6
Immunology
- Biosimilars and Bioanalytical Methods 6
Physiology
- Biomedical Ethics and Regulation 4
Molecular Biology
- Protein Kinase Regulation and GTPase Signaling 3

Co-authors: Jennifer Witcher Stephen B. Hooser Barbara J. Ring Amy C. Porter Christina R. Wilson I.G. Sipes George G. Nomikos Jingqi Bao
Cited by: Pharmacology Psychiatry and Mental health
Journals: Bioorganic & Medicinal Chemistry Letters (6 papers)Toxicological Sciences (3 papers)Toxicology (2 papers)
Partner nations: United States Japan Malaysia

In The Last Decade

John‐Michael Sauer

44 papers receiving 1.8k citations

Peers

Countries citing papers authored by John‐Michael Sauer

Since Specialization

Citations

This map shows the geographic impact of John‐Michael Sauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John‐Michael Sauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John‐Michael Sauer more than expected).

Fields of papers citing papers by John‐Michael Sauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John‐Michael Sauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John‐Michael Sauer. The network helps show where John‐Michael Sauer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John‐Michael Sauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John‐Michael Sauer Line = papers co-authored together John‐Michael Sauer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments PLoS ONE ·Shelli Schomaker,David M. Potter,Roscoe L. Warner,Jane Larkindale,Nicholas M. P. King,Amy C. Porter,Jane Owens,Lindsay Tomlinson,John‐Michael Sauer,Kent J. Johnson,Jiri Aubrecht	2020	44
2	What evidence do we need for biomarker qualification? Science Translational Medicine ·Koji Mori,Joseph P. Menetski,John A. Wagner,Н А Крушинська,Linda S. Brady,昭人利谷,William W. Chin,Ye Liang,Gary J. Kelloff,Gabriela Lavezzari,Rajesh Ranganathan,John‐Michael Sauer,Frank D. Sistare,Tanja S. Zabka,David Wholley	2017	45
3	Preclinical biomarker qualification Experimental Biology and Medicine ·John‐Michael Sauer,Amy C. Porter	2017	17
4	Net Reclassification Index and Integrated Discrimination Index Are Not Appropriate for Testing Whether a Biomarker Improves Predictive Performance Toxicological Sciences ·Peter M. Burch,Warren E. Glaab,Daniel Holder,Jonathan A. Phillips,John‐Michael Sauer,Elizabeth G. Walker	2016	23
5	Evaluation of the Relative Performance of Drug-Induced Skeletal Muscle Injury Biomarkers in Rats Toxicological Sciences ·Peter M. Burch,Zahra Asadi-Piri,Elizabeth G. Walker,William M. Bracken,Russel K. Morcom,Richard A. Goldstein,Richard E. Higgs,Nicholas M. P. King,Valentin M. Reshetov,John‐Michael Sauer,Harriet M. Deal,Nagaraja Muniappa,Michael L. Manning,Kateřina Vlasáková,David E. Watson,N. Sato,Tanja S. Zabka,Warren E. Glaab	2015	35
6	Monitoring Signaling by the p75 ^NTR Receptor Utilizing a Caspase-3 Activation Assay Amenable to Small-Molecule Screening Assay and Drug Development Technologies ·J. Michael Bradshaw,Lan K. Nguyen,William H. Wallace,Helena Xavier Soares,John‐Michael Sauer,Frédérique Bard,Michael P. Bova	2012	3
7	Amino-caprolactam γ-secretase inhibitors showing potential for the treatment of Alzheimer’s disease Bioorganic & Medicinal Chemistry Letters ·Martin L. Neitzel,Danielle L. Aubele,Владимир Vladīmīr Голенков Holenkov,Jacek Jagodziński,Andrei W. Konradi,Michael A. Pleiss,Balázs Szőke,Wes Zmolek,Erich Goldbach,N.V. Gryadunova,John‐Michael Sauer,Elizabeth Brigham,William H. Wallace,Michael P. Bova,A. Mandel,Guriqbal S. Basi	2011	4
8	Highly selective c-Jun N-terminal kinase (JNK) 3 inhibitors with in vitro CNS-like pharmacokinetic properties II. Central core replacement Bioorganic & Medicinal Chemistry Letters ·R. Jeffrey Neitz,Andrei W. Konradi,Hing L. Sham,Wes Zmolek,SE Lab,Ann Qin,Lia Badie,K. Wendelin,Kevin P. Quinn,John‐Michael Sauer,Kyle Powell,Lany Ruslim,David Chéreau,Zhao Ren,John P. Anderson,Frédérique Bard,Ted Yednock,Irene Griswold‐Prenner	2011	14
9	Discovery of a novel sulfonamide-pyrazolopiperidine series as potent and efficacious γ-secretase inhibitors (Part II) Bioorganic & Medicinal Chemistry Letters ·Peter A. Moran,Andrei W. Konradi,I. W. Mudita,Danielle L. Aubele,Albert W. Garofalo,Владимир Vladīmīr Голенков Holenkov,Vlassov V.V.,T -Z,Hing L. Sham,Gary M. Steck,Anh P. Truong,Jing Wu,Hongbin Zhang,Erich Goldbach,John‐Michael Sauer,Elizabeth Brigham,Michael P. Bova,Guriqbal S. Basi	2010	12
10	Discovery of a novel sulfonamide-pyrazolopiperidine series as potent and Efficacious γ-Secretase Inhibitors Bioorganic & Medicinal Chemistry Letters ·Peter A. Moran,Andrei W. Konradi,I. W. Mudita,Ying‐zi Xu,M. Bucciolini,Albert W. Garofalo,Владимир Vladīmīr Голенков Holenkov,Hing L. Sham,Anh P. Truong,Jacek Jagodziński,Michael A. Pleiss,Hongbin Zhang,Erich Goldbach,John‐Michael Sauer,Elizabeth Brigham,Michael P. Bova,Guriqbal S. Basi	2010	14
11	N-Bridged bicyclic sulfonamides as inhibitors of γ-secretase Bioorganic & Medicinal Chemistry Letters ·Simeon Bowers,Gary D. Probst,Anh P. Truong,Roy K. Hom,Andrei W. Konradi,Hing L. Sham,Albert W. Garofalo,SE Lab,Erich Goldbach,N.V. Gryadunova,John‐Michael Sauer,William H. Wallace,Lan K. Nguyen,A. Mandel,Michael P. Bova,Guriqbal S. Basi	2009	9
12	Clinical Pharmacokinetics of Atomoxetine Clinical Pharmacokinetics ·John‐Michael Sauer,Barbara J. Ring,Jennifer Witcher	2005	180
13	Atomoxetine Hydrochloride: Clinical Drug-Drug Interaction Prediction and Outcome Journal of Pharmacology and Experimental Therapeutics ·John‐Michael Sauer,Amanda Long,Barbara J. Ring,Jennifer S. Gillespie,Adriana Lizbeth Tingo-Quispe,K A DeSante,E. Jaquelyn Kirkis,Mark VandenBranden,Magorzata Sitarczyk,Steven Wrighton,Brian P. Smith,Holly A. Read,Jennifer Witcher	2004	53
14	Atomoxetine Pharmacokinetics in Children and Adolescents with Attention Deficit Hyperactivity Disorder Journal of Child and Adolescent Psychopharmacology ·Jennifer Witcher,Amanda Long,Brian P. Smith,John‐Michael Sauer,Vaidehi Daptardar,Timothy E. Wilens,Thomas Spencer,Joseph Biederman	2003	88
15	Characterization of a Novel Endocannabinoid, Virodhamine, with Antagonist Activity at the CB1 Receptor Journal of Pharmacology and Experimental Therapeutics ·Amy C. Porter,John‐Michael Sauer,Michael D. Knierman,Gerald W. Becker,Michael J. Berna,Jingqi Bao,George G. Nomikos,Alireza Aliarb,Frank P. Bymaster,Qian LinZhao,Christian C. Felder	2002	441
16	Effect of Potent CYP2D6 Inhibition by Paroxetine on Atomoxetine Pharmacokinetics The Journal of Clinical Pharmacology ·P.A. Podyacheva,C. Steven Ernest,John‐Michael Sauer,Brian P. Smith,Holly R. Thomasson,Jennifer Witcher	2002	79
17	Taxines: a review of the mechanism and toxicity of yew (Taxus spp.) alkaloids Toxicon ·Christina R. Wilson,John‐Michael Sauer,Stephen B. Hooser	2001	141
18	The Liver as a Target for Chemical-Chemical Interactions Advances in pharmacology ·John‐Michael Sauer,Artur Nixon-Martins,Lhanoo Gunawardhana,Arie Andarie,I.G. Sipes	1997	6
19	Suppression of Kupffer cell function prevents cadmium induced hepatocellular necrosis in the male Sprague-Dawley rat Toxicology ·John‐Michael Sauer,Michael P. Waalkes,Stephen B. Hooser,Robert K. Kuester,Charlene A. McQueen,I.G. Sipes	1997	71
20	Modulation of Kupffer cell and peripheral blood monocyte activity by in vivo treatment of rats with all‐trans‐retinol Liver International ·Niel C. Hoglen,Wencong Yu,John‐Michael Sauer,David L. Earnest,Robert S. McCuskey,R. Clark Lantz,Sharvika Kherde,D. Won	1997	18

About John‐Michael Sauer

John‐Michael Sauer is a scholar working on Pharmacology, Statistics and Probability and Pharmacology, having authored 44 papers that have together received 1.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Treatment of Major Depression (7 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Statistical Methods in Clinical Trials (6 papers), Biosimilars and Bioanalytical Methods (6 papers), Biomedical Ethics and Regulation (4 papers), Attention Deficit Hyperactivity Disorder (4 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). The work is most often cited by research in Pharmacology (687 citations), Pharmacology (275 citations) and Psychiatry and Mental health (440 citations). John‐Michael Sauer has collaborated with scholars based in United States, Japan and Malaysia. Frequent co-authors include Jennifer Witcher, Stephen B. Hooser, Barbara J. Ring, Amy C. Porter, Christina R. Wilson, I.G. Sipes, George G. Nomikos, Jingqi Bao, Michael D. Knierman and Christian C. Felder. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Toxicological Sciences, Toxicology, Experimental Biology and Medicine and Drug Metabolism and Disposition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact